Athero Review - Issue 3/2025
Abstract Book
Editorial
147
Guidelines
151
Cardio-renal-metabolic syndrome: statement by the Czech Society for Atherosclerosis Committee – year 2025
Hana Rosolová, Jan Piťha, Tomáš Freiberger, Pavel Kraml, Vladimír Blaha, Renata Cífková, David Karásek, Vladimír Soška, Tomáš Štulc, Michal Vrablík, Lukáš Zlatohlávek
Reviews
161
The event is not a coincidence, or the need for long-term and effective cardiovascular risk control
Martin Šatný, Michal Vrablík
174
178
183
Evinacumab – one year of experience in patients with homozygous familial hypercholesterolemia: case reports
Lukáš Zlatohlávek, Jana Beňová Becherová, Jaroslav A. Hubáček
189
Comprehensive lipid-lowering therapy and cardiovascular risk reduction: a case report
Martina Šišáková, Kateřina Helánová
193
196
Update to ESC/EAS recommendations for dyslipidemia: what‘s new?
Kristýna Čillíková
From International Literature
Athero Review
2025 Issue 3
Most read in this issue
- Cardio-renal-metabolic syndrome: statement by the Czech Society for Atherosclerosis Committee – year 2025
- The event is not a coincidence, or the need for long-term and effective cardiovascular risk control
- Research on remarkable articles from international literature
- Interactions (not only between genes and the environment) and cardiovascular disease